bibliographic resource 2998499 [br/2998499]
https://w3id.org/oc/corpus/br/2998499
- is a
-
- title
-
- KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-